Clinical Trial Update: VA Augmentation and Switching Treatments for Improving Depression Outcomes [Phase 3]

View source ↗

Summary

Phase 3 VA study evaluating augmentation and switching strategies to improve outcomes in adults with major depressive disorder. Results were posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: VA Office of Research and Development | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-05-29